Traduzione e analisi delle parole tramite l'intelligenza artificiale ChatGPT
In questa pagina puoi ottenere un'analisi dettagliata di una parola o frase, prodotta utilizzando la migliore tecnologia di intelligenza artificiale fino ad oggi:
- come viene usata la parola
- frequenza di utilizzo
- è usato più spesso nel discorso orale o scritto
- opzioni di traduzione delle parole
- esempi di utilizzo (varie frasi con traduzione)
- etimologia
Cosa (chi) è nonalcoholic$53001$ - definizione
![obese]] individuals with NAFLD or NASH, [[bariatric surgery]] improves or cures the liver disease if there is no [[cirrhosis]] nor [[liver cancer]].](https://commons.wikimedia.org/wiki/Special:FilePath/Bariatric surgery in NAFLD.jpg?width=200 "obese]] individuals with NAFLD or NASH, [[bariatric surgery]] improves or cures the liver disease if there is no [[cirrhosis]] nor [[liver cancer]].")
![biopsy]], which is then examined under a microscope](https://commons.wikimedia.org/wiki/Special:FilePath/Human liver biopsy sample.jpg?width=200 "biopsy]], which is then examined under a microscope")
![[[Micrograph]] of non-alcoholic fatty liver disease, demonstrating marked [[steatosis]] (fat in liver cells appears white; connective tissue, blue). [[Trichrome stain]]](https://commons.wikimedia.org/wiki/Special:FilePath/Non-alcoholic fatty liver disease1.jpg?width=200 "[[Micrograph]] of non-alcoholic fatty liver disease, demonstrating marked [[steatosis]] (fat in liver cells appears white; connective tissue, blue). [[Trichrome stain]]")
![Mallory-Denk body]]](https://commons.wikimedia.org/wiki/Special:FilePath/Mallory_body_high_mag_cropped_annotated.jpg?width=200 "Mallory-Denk body]]")
![[[Ballooning degeneration]]](https://commons.wikimedia.org/wiki/Special:FilePath/Ballooning_degeneration_high_mag_cropped_annotated.jpg?width=200 "[[Ballooning degeneration]]")
Wikipedia
Non-alcoholic fatty liver disease (NAFLD), also known as metabolic (dysfunction) associated fatty liver disease (MAFLD), is excessive fat build-up in the liver without another clear cause such as alcohol use. There are two types; non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH), with the latter also including liver inflammation. Non-alcoholic fatty liver is less dangerous than NASH and usually does not progress to NASH. When NAFL does progress to NASH, it may eventually lead to complications such as cirrhosis, liver cancer, liver failure, or cardiovascular disease.
Obesity and type 2 diabetes are strong risk factors for NAFLD. Other risks include being overweight, metabolic syndrome (defined as at least three of the five following medical conditions: abdominal obesity, high blood pressure, high blood sugar, high serum triglycerides, and low serum HDL cholesterol), a diet high in fructose, and older age. NAFLD and alcoholic liver disease are types of fatty liver disease. Obtaining a sample of the liver after excluding other potential causes of fatty liver can confirm the diagnosis.
Treatment for NAFLD is weight loss by dietary changes and exercise. There is tentative evidence for pioglitazone and vitamin E; and bariatric surgery can improve or resolve severe cases. Those with NASH have a 2.6% increased risk of dying per year.
NAFLD is the most common liver disorder worldwide and is present in approximately 25% of the world's population. It is very common in developed nations, such as the United States, and affected about 75 to 100 million Americans in 2017. Over 90% of obese, 60% of diabetic, and up to 20% of normal-weight people develop NAFLD. NAFLD is the leading cause of chronic liver disease and the second most common reason for liver transplantation in the US and Europe as of 2017. NAFLD affects about 20 to 25% of people in Europe. In the United States, estimates suggest between 30 and 40% of adults have NAFLD, and about 3 to 12% of adults have NASH. The annual economic burden was approximately US$103 billion in the US in 2016.
